Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-trimoxazole prophylaxis for children with recurrent respiratory tract infections
NL-OMON54555Phase 3Completed
- Sponsor
- HagaZiekenhuis
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in recurrent respiratory tract infection (RRTI) comparing Co-trimoxazole prophylaxis with Placebo (2 arms). Started Jan 2019; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
recurrent respiratory tract infection (RRTI)
Beyond the preview
Go deeper on NL-OMON54555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54555.